 |
|
|
| |
Phase 2 Randomized, Double-Blind Placebo-Controlled Study of Nitazoxanide with Peginterferon Alfa-2a and Ribavirin in Nonresponders with Chronic Hepatitis C Genotype 1: Final Report
|
| |
| |
Reported by Jules Levin
EASL Apr 14-18 2010 Vienna Austria
M.L. Shiffman A Ahmed, I.M. Jacobson, R.E, Pruitt, E.B. Keefe, USA
|
| |
|
|
|
|
|
